Neovasc Inc.(NVCN)

Sector:

Healthcare

Description:

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Current Price

$30.03

RSI

70.41

Market Capitalization:

44.6M

Beta:

2.946

Volume:

45,477

Analyst Target Price:

$ 1.88

Economiic Fair Price:


November 10, 2022
September 30, 2022
Q3
N/A
N/A
N/A
N/A
N/A
-0.446
N/A
0.044
-0.795

35.25 %
-88.82 %
20.23 %
45.85 %
9.08 %
7.59 %

$ 2.5M
30.14 %
$ 2M
-6.44 %
$ 2.1M
19.60 %
$ 1.7M
-67.54 %
$ 5.4M
-43.35 %
$ 9.5M

$ -27.3M
8.42 %
$ -29.8M
-22.99 %
$ -24.2M
-5.35 %
$ -23M
83.48 %
$ -139.1M
-243.93 %
$ -40.5M

$ -24.8M
15.12 %
$ -29.2M
16.76 %
$ -35.1M
67.48 %
$ -107.9M
-381.33 %
$ -22.4M
74.01 %
$ -86.3M

News

Press Releases

Notable Dates